RA Capital Management

RA Capital Management

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Boston


RA Capital Management is the renowned VC, which was created in 2001. The the headquarters of this VC is in Boston. The VC's location is in North America, United States.

This VC was founded by Richard Aldrich. We also identified another 4 core personnel in our database.

The fund typically invests in rounds with 6-7 participants. Along with RA Capital Management, start-ups are often financed by OrbiMed, F-Prime Capital, Flybridge Capital Partners as well as 89 other investors. The most common co-investors for the fund are Wellington Management, Longitude Capital, Deerfield and also 123 different VCs. In subsequent rounds, the fund is usually supported by OrbiMed, Cormorant Asset Management, Polaris Partners, out of 41 investors from our database.

The fund performance shows that this VC achieves 4 percentage points more exits in comparison to other VCs. We recorded the biggest number of exits for this fund in 2015. In 2015, the fund's activity was at its peak. Additionally, in 2019 the fund was active. The fund generally invests in 7-12 deals every year. The most common rounds for this fund are in the range of 50 - 100 millions dollars. The average start-up valuation at the time of investment from RA Capital Management is more than 1 billion dollars. RA Capital Management is involved in 23 percentage points more than the average amount of lead investments when compared with other funds.

The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 6 other locations. Among their most successful investment fields, we have identified Health Care, Health Diagnostics. Also, because of its portfolio diversification tendency, we can highlight 16 more industries for this fund. Moreover, a start-up needs to be 6-10 years old to get investment from this fund. AveXis, Moderna Therapeutics, Intarcia Therapeutics are amongst the various portfolio companies of this fund. The fund has no a preferred number of founders for start-ups that it invests in. If there are 5+ founders in the start-up, the probability of getting the investment is low.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: racap.com; User name format in descending order of probability: first_initial last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

15.0% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

3.5 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.73 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]


Funds Investing in Previous

OrbiMed, F-Prime Capital, Flybridge Capital Partners

Funds Investing in Following

OrbiMed, Cormorant Asset Management, Polaris Partners

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: